BackTerns Pharmaceuticals Overview

Terns Pharmaceuticals Current Cash

Track Terns Pharmaceuticals's current cash ($520M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$524.75M
↑ 225.04% YoYΔ $363.31M vs prior year quarter

Peer trimmed avg / median

Loading

Terns Pharmaceuticals Current Cash History

Loading

Terns Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Terns Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Terns Pharmaceuticals (TERN) FAQ

Terns Pharmaceuticals (TERN) currently reports a current cash of $520M as of December 2025. That compares with $160M in the prior-year period — up 225.0% year over year. Use the charts on this page to explore Terns Pharmaceuticals's current cash history and peer comparisons.

Terns Pharmaceuticals's current cash increased from $160M to $520M — a 225.0% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Terns Pharmaceuticals reported $520M in current cash as of December 2025. That compares with $160M in the prior-year period — up 225.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $520M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Terns Pharmaceuticals, and consider following TERN for alerts when major investors trade the stock.

Terns Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $520M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TERN with unrelated industries.